Navb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Navb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Navb Today - Breaking & Trending Today

Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NAVB opened at $0.04 on Monday. The company has a 50-day simple moving average of $0.04 and a 200-day simple […] ....

Therapeutic Development Programs , Navidea Biopharmaceuticals Inc , Navidea Biopharmaceuticals Company Profile , Navidea Biopharmaceuticals , Free Report , Get Free Report , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,

Navidea Biopharmaceuticals (NYSE:NAVB) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Monday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NAVB stock opened at $0.04 on Monday. The stock’s fifty day moving average is $0.04 and its 200-day […] ....

Therapeutic Development Programs , Navidea Biopharmaceuticals Inc , Navidea Biopharmaceuticals Company Profile , Navidea Biopharmaceuticals , Free Report , Get Free Report , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,

Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Performance Navidea Biopharmaceuticals stock opened at $0.04 on Friday. Navidea Biopharmaceuticals has a twelve month low of […] ....

Therapeutic Development Programs , Exchange Commission , Navidea Biopharmaceuticals Inc , Navidea Biopharmaceuticals Company Profile , Navidea Biopharmaceuticals , Get Free Report , Street Corp , Free Report , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on Navidea Biopharmaceuticals (NYSE:NAVB)

StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of NAVB opened at $0.04 on Friday. The firm has a market capitalization of $3.95 million, a price-to-earnings ratio […] ....

Navidea Biopharmaceuticals Inc , Renaissance Technologies , Therapeutic Development Programs , Exchange Commission , Navidea Biopharmaceuticals , Free Report , Get Free Report , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,

Navidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note published on Thursday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Navidea Biopharmaceuticals stock opened at $0.04 on Thursday. The firm has a market capitalization of $4.09 million, a PE ratio of -0.68 and […] ....

Navidea Biopharmaceuticals Company Profile , Navidea Biopharmaceuticals Inc , Therapeutic Development Programs , Navidea Biopharmaceuticals , Free Report , Get Free Report , Street Corp , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,